Pfizer Collaborates with FibriCheck and AlTibbi to Launch the First of Its Kind Atrial Fibrillation Screening Program in the UAE
Pfizer is further highlighting its commitment on becoming a more patient-centric company by launching the first of its kind screening program in collaboration with FibriCheck and AlTibbi, to detect Atrial Fibrillation disease, in the UAE. Atrial fibrillation is one of the most common heart rhythm disorders that result in irregular heartbeats often leading to a stroke. Characterized by its fickle nature, it can even present no symptoms at all which makes it a difficult disorder to obtain proper diagnosis for. As a result, Pfizer will provide patients at a high risk of Atrial Fibrillation with an innovative digital solution through … Continue reading Pfizer Collaborates with FibriCheck and AlTibbi to Launch the First of Its Kind Atrial Fibrillation Screening Program in the UAE